HIGHLAND, Utah–(BUSINESS WIRE)–New discovery may have a major impact on treating Parkinson’s disease through the eyes.
Uncategorized
Uncategorized
FDA approves BromSite to treat inflammation, prevent pain in cataract surgery
The FDA has approved BromSite to treat postoperative inflammation and prevent ocular pain in patients who undergo cataract surgery, according to a press release from Sun Pharma. BromSite (bromfenac ophthalmic solution 0.075%) is the first NSAID approve…
Uncategorized
Premature infants without ROP still at risk for ocular pathology
VANCOUVER, British Columbia — Ocular pathology may be missed in premature infants with no or mild retinopathy of prematurity who are not followed up beyond 12 months of age, according to a scientific poster presented here at the American Association for Pediatric Ophthalmology and Strabismus meeting. Christine Law, MD, and colleagues from Children’s Hospital of Philadelphia, conducted a retrospective consecutive cohort study of infants born at gestational age less than 37 weeks and followed up for 6 months or more. Incidence and age at diagnosis of strabismus, nystagmus, and high myopia or hyperopia were analyzed and stratified by worst documented stage of ROP.
Uncategorized
VIDEO: Update on dermal fillers
At Hawaiian Eye, Femida Kherani, MD, shares pearls on using dermal fillers in an ophthalmic practice.
Uncategorized
Inotek Pharmaceuticals Announces the Journal of Ocular Pharmacology and Therapeutics has Published its Phase 2 Data for Trabodenoson in Patients with Glaucoma and Ocular Hypertension
LEXINGTON, Mass.–(BUSINESS WIRE)–Inotek announced that the Journal of Ocular Pharmacology and Therapeutics published results from a Phase 2 study of the Company’s lead product candidate, trabodenoson, in patients with POAG or OHT.
Uncategorized
Lactante presenta lagrimeo, secreciones de ambos ojos
Una lactante de 4 meses de edad, previamente sana y nacida a término, fue presentada al pediatra con lagrimeo y secreciones de ambos ojos. La madre observó que esto había estado presente desde el nacimiento y no observó síntomas asociados. Durante el examen, el pediatra observó un desarrollo normal y lagrimeo bilateral. A la niña se la diagnosticó con obstrucción del conducto nasolagrimal. Se le recomendaron masajes nasolagrimales y compresas tibias.A la paciente se la envió a casa; no obstante, una semana después regresó a la sala de urgencias con inyección en el ojo derecho y edema leve alrededor del ojo derecho. Estuvo alegre durante el examen y tuvo una ingesta/eliminación adecuadas a su edad. En la sala de urgencias se le prescribieron gotas para ojos de polimixina B-trimetoprima y se le dio de alta a la paciente nuevamente.